by University of California, San Francisco | Oct 8, 2020 | Oncology
Though cancer immunotherapy has become a promising standard-of-care treatment—and in some cases, perhaps a cure—for a wide variety of different cancers, it doesn’t work for everyone, and researchers have increasingly turned their attention to understanding why....
by Hokkaido University | Aug 25, 2020 | Breast Cancer, Oncology
Breast cancer is the most common cancer among women across the world, affecting 28.9% . Depending on the combination of cell receptor molecules present on the surface of the cancer cells, breast cancer is classified into one of three types: Luminal A, Luminal B and...
by Jennifer Reiley, Texas A&M University | Aug 20, 2020 | BioPharma, News, Oncology
Dr. Abhishek Jain, assistant professor in the Department of Biomedical Engineering and the Department of Medical Physiology in the College of Medicine, collaborated with researchers from the Departments of Gynecologic Oncology and Cancer Biology at MD Anderson Cancer...
by University of Missouri | Jul 24, 2020 | BioPharma, Oncology
Osteosarcoma, a common bone cancer in dogs, affects more than 10,000 dogs in the U.S. each year. While chemotherapy is generally effective at killing some of the cells, the numerous side effects can be painful and often a subset of cells exist that are resistant to...
by St. Jude Children's Research Hospital | Jun 30, 2020 | Mobile Health, News, Oncology
An innovative, interactive cloud-based data portal debuted this week that lets academic researchers mine the world’s largest and most comprehensive collection of scientific resources for studying pediatric solid tumors and their related biology. The Childhood...
by Chinese Academy of Sciences | May 26, 2020 | News, Oncology
Developing safe and efficient bioformulations using approved materials and ingenious designs can accelerate the clinical translation process. Scientists from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a new therapeutic...
